PATENT CLAIM ANALYSIS

Application Number: 16021540
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "069700"]

Abstract:
The present invention provides a method for designing a re-targeted toxin conjugate for use in treating a medical condition or disease. Also provided, is the use of said conjugates in the manufacture of a medicament for treating medical conditions or diseases. The conjugates include a Targeting Moiety, which directs the conjugate to a desired target cell, and are characterised by a Targeting Moiety that increases exocytic fusion in the target cell. The present invention also provides methods for identifying agonists suitable for use as Targeting Moieties, and methods for preparing conjugates comprising said Targeting Moieties.

Claim (Index 2):
The method of  claim 1 , wherein step (a) comprises:\n confirming said polypeptide agonist molecule is an agonist by identifying an increase in secretion of said extracellular mediator from the target cell following binding of the polypeptide agonist to the target cell.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.80702
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13944427', '11792210', '13212868', '13343892', '15258282']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6565297078204736
- 35 USC 102 Novelty (BERT): 0.515515851914065
- Combined Prediction Score: 0.6424283222298327
- Mean Citation Score: 283.229752
- Max Citation Score: 292.6719
- Similarity Product: 182.3534414090753

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test